These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 10069788

  • 1. Vasodilator therapy for primary pulmonary hypertension in children.
    Barst RJ, Maislin G, Fishman AP.
    Circulation; 1999 Mar 09; 99(9):1197-208. PubMed ID: 10069788
    [Abstract] [Full Text] [Related]

  • 2. Recent advances in the treatment of pediatric pulmonary artery hypertension.
    Barst RJ.
    Pediatr Clin North Am; 1999 Apr 09; 46(2):331-45. PubMed ID: 10218078
    [Abstract] [Full Text] [Related]

  • 3. Outcomes in children with idiopathic pulmonary arterial hypertension.
    Yung D, Widlitz AC, Rosenzweig EB, Kerstein D, Maislin G, Barst RJ.
    Circulation; 2004 Aug 10; 110(6):660-5. PubMed ID: 15289375
    [Abstract] [Full Text] [Related]

  • 4. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.
    Rosenzweig EB, Kerstein D, Barst RJ.
    Circulation; 1999 Apr 13; 99(14):1858-65. PubMed ID: 10199883
    [Abstract] [Full Text] [Related]

  • 5. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T, Ozawa Y, Nakayama T, Matsuura H, Hashiguchi R, Matsuo N, Muto H, Yamazaki J, Morishita T, Saito T.
    J Cardiol; 1996 Apr 13; 27(4):197-205. PubMed ID: 8642506
    [Abstract] [Full Text] [Related]

  • 6. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    McLaughlin VV, Genthner DE, Panella MM, Rich S.
    N Engl J Med; 1998 Jan 29; 338(5):273-7. PubMed ID: 9445406
    [Abstract] [Full Text] [Related]

  • 7. Nitric oxide and prostacyclin as test agents of vasoreactivity in severe precapillary pulmonary hypertension: predictive ability and consequences on haemodynamics and gas exchange.
    Jolliet P, Bulpa P, Thorens JB, Ritz M, Chevrolet JC.
    Thorax; 1997 Apr 29; 52(4):369-72. PubMed ID: 9196521
    [Abstract] [Full Text] [Related]

  • 8. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.
    Sitbon O, Humbert M, Jagot JL, Taravella O, Fartoukh M, Parent F, Herve P, Simonneau G.
    Eur Respir J; 1998 Aug 29; 12(2):265-70. PubMed ID: 9727772
    [Abstract] [Full Text] [Related]

  • 9. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
    Houde C, Bohn DJ, Freedom RM, Rabinovitch M.
    Br Heart J; 1993 Nov 29; 70(5):461-8. PubMed ID: 8260279
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension.
    Raffy O, Azarian R, Brenot F, Parent F, Sitbon O, Petitpretz P, Hervé P, Duroux P, Dinh-Xuan AT, Simonneau G.
    Circulation; 1996 Feb 01; 93(3):484-8. PubMed ID: 8565165
    [Abstract] [Full Text] [Related]

  • 11. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension.
    Preston IR, Klinger JR, Landzberg MJ, Houtchens J, Nelson D, Hill NS.
    Chest; 2001 Sep 01; 120(3):866-72. PubMed ID: 11555522
    [Abstract] [Full Text] [Related]

  • 12. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.
    Pneumologie; 2000 Mar 01; 54(3):133-42. PubMed ID: 10783653
    [Abstract] [Full Text] [Related]

  • 13. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension.
    Friedman R, Mears JG, Barst RJ.
    Circulation; 1997 Nov 04; 96(9):2782-4. PubMed ID: 9386137
    [Abstract] [Full Text] [Related]

  • 14. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.
    Sitbon O, Brenot F, Denjean A, Bergeron A, Parent F, Azarian R, Herve P, Raffestin B, Simonneau G.
    Am J Respir Crit Care Med; 1995 Feb 04; 151(2 Pt 1):384-9. PubMed ID: 7842196
    [Abstract] [Full Text] [Related]

  • 15. Primary pulmonary hypertension: Current therapy.
    Sitbon O, Humbert M, Simonneau G.
    Prog Cardiovasc Dis; 2002 Feb 04; 45(2):115-28. PubMed ID: 12411973
    [Abstract] [Full Text] [Related]

  • 16. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
    Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Hervé P, Simonneau G.
    Circulation; 2005 Jun 14; 111(23):3105-11. PubMed ID: 15939821
    [Abstract] [Full Text] [Related]

  • 17. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension.
    Rich S, Brundage BH, Levy PS.
    Circulation; 1985 Jun 14; 71(6):1191-6. PubMed ID: 3995712
    [Abstract] [Full Text] [Related]

  • 18. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.
    McLaughlin VV, Shillington A, Rich S.
    Circulation; 2002 Sep 17; 106(12):1477-82. PubMed ID: 12234951
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of intravenous adenosine in idiopathic pulmonary arterial hypertension as a screening agent for identifying long-term responders to calcium channel blockers.
    Zuo XR, Zhang R, Jiang X, Li XL, Zong F, Xie WP, Wang H, Jing ZC.
    Am J Cardiol; 2012 Jun 15; 109(12):1801-6. PubMed ID: 22459309
    [Abstract] [Full Text] [Related]

  • 20. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.
    Montalescot G, Drobinski G, Meurin P, Maclouf J, Sotirov I, Philippe F, Choussat R, Morin E, Thomas D.
    Am J Cardiol; 1998 Sep 15; 82(6):749-55. PubMed ID: 9761085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.